Kraig Biocraft Laboratories, Inc Insider Trading Activity
Every SEC Form 4 insider transaction reported for Kraig Biocraft Laboratories, Inc (KBLB), sourced directly from SEC EDGAR and updated as new filings are accepted.
Quick Answer
Are KBLB insiders buying or selling?
Kraig Biocraft Laboratories, Inc insiders reported 0 open-market buys ($0) and 73 sells ($0) across 73 Form 4 filings — a net buying position of $0.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 21, 2022)
Insider sentiment
BalancedNet insider flow of $0 in net buying.
Recent KBLB insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 21, 2022 | Kimberly Kraig Thompson | CEO & CFO | Sale | 170.0K | $0.00 | $0 |
| Jul 19, 2022 | Kimberly Kraig Thompson | CEO & CFO | Sale | 129.9K | $0.00 | $0 |
| Jul 15, 2022 | Kimberly Kraig Thompson | CEO & CFO | Sale | 11.5K | $0.00 | $0 |
| Jul 13, 2022 | Kimberly Kraig Thompson | CEO & CFO | Sale | 100.0K | $0.00 | $0 |
| Jul 11, 2022 | Kimberly Kraig Thompson | CEO & CFO | Sale | 60.0K | $0.00 | $0 |
| Jul 7, 2022 | Kimberly Kraig Thompson | CEO & CFO | Sale | 80.0K | $0.00 | $0 |
| Jul 1, 2022 | Kimberly Kraig Thompson | CEO & CFO | Sale | 20.0K | $0.00 | $0 |
| Jun 29, 2022 | Kimberly Kraig Thompson | CEO & CFO | Sale | 80.0K | $0.00 | $0 |
| Jun 24, 2022 | Kimberly Kraig Thompson | CEO & CFO | Sale | 110.0K | $0.00 | $0 |
| Jun 23, 2022 | Kimberly Kraig Thompson | CEO & CFO | Sale | 210.0K | $0.00 | $0 |
| Jun 21, 2022 | Kimberly Kraig Thompson | CEO & CFO | Sale | 100.0K | $0.00 | $0 |
| Jun 17, 2022 | Kimberly Kraig Thompson | CEO & CFO | Sale | 10.0K | $0.00 | $0 |
| Jun 10, 2022 | Kimberly Kraig Thompson | CEO & CFO | Sale | 20.0K | $0.00 | $0 |
| Jun 8, 2022 | Kimberly Kraig Thompson | CEO & CFO | Sale | 10.5K | $0.00 | $0 |
| Jun 3, 2022 | Kimberly Kraig Thompson | CEO & CFO | Sale | 30.0K | $0.00 | $0 |
| Jun 1, 2022 | Kimberly Kraig Thompson | CEO & CFO | Sale | 30.0K | $0.00 | $0 |
| May 27, 2022 | Kimberly Kraig Thompson | CEO & CFO | Sale | 65.0K | $0.00 | $0 |
| May 25, 2022 | Kimberly Kraig Thompson | CEO & CFO | Sale | 20.0K | $0.00 | $0 |
| May 23, 2022 | Kimberly Kraig Thompson | CEO & CFO | Sale | 40.0K | $0.00 | $0 |
| May 19, 2022 | Kimberly Kraig Thompson | CEO & CFO | Sale | 40.0K | $0.00 | $0 |
| May 16, 2022 | Kimberly Kraig Thompson | CEO & CFO | Sale | 42.5K | $0.00 | $0 |
| May 12, 2022 | Kimberly Kraig Thompson | CEO & CFO | Sale | 30.0K | $0.00 | $0 |
| May 9, 2022 | Kimberly Kraig Thompson | CEO & CFO | Sale | 2.0K | $0.00 | $0 |
| May 6, 2022 | Kimberly Kraig Thompson | CEO & CFO | Sale | 11.4K | $0.00 | $0 |
| May 4, 2022 | Kimberly Kraig Thompson | CEO & CFO | Sale | 32.0K | $0.00 | $0 |
Showing the 25 most recent of 73 Form 4 filings for Kraig Biocraft Laboratories, Inc.
Most active KBLB insiders
- Kimberly Kraig Thompson73 filings
Ask anything about KBLB insider activity
Use Trabud's AI agent to query Kraig Biocraft Laboratories, Inc's Form 4 history in plain English — "Show me KBLB CEO purchases this year" or compare it against any other ticker.
Open the AI agentKBLB insider trading FAQ
Are Kraig Biocraft Laboratories, Inc insiders buying or selling?
Across 73 SEC Form 4 filings, Kraig Biocraft Laboratories, Inc (KBLB) insiders reported 0 open-market purchases totaling $0 and 73 sales totaling $0. That is a net buying position of $0.
How many insiders trade KBLB stock?
1 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Kraig Biocraft Laboratories, Inc. The most recent filing was accepted on Jul 21, 2022.
Where does Trabud get KBLB insider trading data?
All KBLB insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.